During the past decade, Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 3 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego" #1 sponsor was "Pfizer" with 2 trials, followed by "Biogen" with 1 trials sponsored, "Celgene" with 1 trials sponsored, "Jiangsu HengRui Medicine Co., Ltd." with 1 trials sponsored and "Phenox GmbH" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego" #1 collaborator was "Astellas Pharma Inc" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego" are "Castration-Resistant Prostate Cancer" (1 trials), "Intracranial Aneurysm" (1 trials), "Metastatic Castration-Resistant Prostate Cancer (mCRPC)" (1 trials), "Multiple Sclerosis" (1 trials) and "Neutropenia" (1 trials). Many other conditions were trialed in "Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego" in a lesser frequency.

Most popular intervention types in "Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Avonex" (1 trials), "BIIB033" (1 trials), "Bacillus Calmette-Guerin" (1 trials) and "Cyclophosphamide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego" are 5 trials for "All" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".

Regionalny Szpital Specjalistyczny im. dr Wladyslawa Bieganskiego has several departments that took part in Clinical trials: "Regionalny Szpital Specjalistyczny im. W. Bieganskiego; Oddzial Onkologii Klinicznej" - 3 trials